Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132577) titled 'A Study on the Efficacy of Lemborexant in Patients with Insomnia of the Hyperarousal Subtype and Comorbid Cardiovascular Risk' on Sept. 15.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Insomnia
Intervention:
Non-hyperarousal insomnia group:Treatment with lemborexant
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Non-hyperarousal insomnia group:55;Hyperarousal insomnia group:55;
Countries of Recruitment:
China
To know more, visit https://www.chictr...